Linkage of clinical trial and administrative data: a survey of cancer patient preferences

被引:17
|
作者
Hay, A. E. [1 ,2 ]
Leung, Y. W. [3 ]
Pater, J. L. [1 ]
Brown, M. C. [4 ]
Bell, E. [5 ]
Howell, D. [4 ]
Kassam, Z. [4 ,6 ]
Willing, S. [7 ]
Tian, C. [4 ]
Liu, G. [4 ]
机构
[1] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
[2] Queens Univ, Dept Med, Kingston, ON, Canada
[3] Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[4] Univ Hosp Network, Toronto, ON, Canada
[5] Clin Trials Ontario, Toronto, ON, Canada
[6] Southlake Reg Hlth Ctr, Stronach Reg Canc Ctr, Dept Radiat Oncol, Newmarket, Suffolk, England
[7] Kingston Gen Hosp, Canc Ctr Southeastern Ontario, Kingston, ON, Canada
关键词
Survey; clinical trials; consent; data linkage; DESIGN;
D O I
10.3747/co.24.3400
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Personal health information, including diagnoses and hospital admissions, is routinely collected in administrative databases. Patients enrolling on clinical trials consent to separate collection and storage of their personal health information. We evaluated patient preferences for linking long-term data from administrative databases with clinical trials. Methods Adults with cancer attending outpatient clinics at 3 Ontario hospitals were surveyed about their willingness, when faced with the hypothetical scenario of participating in a clinical trial, to provide potentially identifying information such as initials and date of birth to facilitate long-term research access to normally de-identified publicly collected databases. Results Of 569 patients surveyed, 335 (59%) were women, 452 (79%) were white, 385 (68%) had a post-secondary education, and 386 (68%) had never participated in a clinical trial. Median age in the group was 59 years. Most participants (93%, cohort 1) would allow long-term access to their information and allow personal information to be used to match clinical trial with administrative data. At the time of clinical trial closure, two thirds of participants (68%, cohort 2) preferred to make additional clinical information available through linkage with administrative databases, and 8 (9%) preferred to have no further information made available to researchers. No significant differences were found in the subset of patients who were part of a clinical trial and those who had never participated (p = 0.65). Interpretation Almost all patients would allow a clinical trial research team to access their confidential information, providing a more comprehensive assessment of an intervention's long-term risks and benefits.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 50 条
  • [1] Patient preferences for research access to administrative data in Ontario
    Tian, Chenchen
    Brown, Catherine
    Cosio, Andrea Perez
    Leung, Yvonne
    Lagrotteria, Alisa
    Liang, Mindy
    Gill, Gursharan
    Wong, Lauren
    Sinnesael, Kendra
    Noronha, Cheryl
    Willing, Stephanie
    Bell, Erin N.
    Vennettilli, Ashlee
    Edwards, Jackie
    Pater, Joseph L.
    Howell, Doris
    Kassam, Zahra
    Liu, Geoffrey
    Hay, Annette E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03)
  • [2] Facioscapulohumeral muscular dystrophy European patient survey: assessing patient preferences in clinical trial participation
    McNiff, M.
    Hawkins, S.
    Haase, B.
    Bullivant, J.
    McIver, T.
    Mitelman, O.
    Emery, N.
    Tasca, G.
    Voermans, N.
    Diaz-Manera, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S121 - S121
  • [3] Understanding the determinants of consent for linkage of administrative health data with a longitudinal survey
    Carter, K.
    Shaw, C.
    Hayward, M.
    Blakely, T.
    KOTUITUI-NEW ZEALAND JOURNAL OF SOCIAL SCIENCES ONLINE, 2010, 5 (02): : 53 - 60
  • [4] Survey Consent to Administrative Data Linkage: Five Experiments on Wording and Format
    Jaeckle, Annette
    Burton, Jonathan
    Couper, Mick P.
    Crossley, Thomas F.
    Walzenbach, Sandra
    JOURNAL OF SURVEY STATISTICS AND METHODOLOGY, 2023, 12 (05) : 1174 - 1199
  • [5] Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?
    Hanna, Timothy P.
    Nguyen, Paul
    Pater, Joseph
    O'Callaghan, Christopher J.
    Mittmann, Nicole
    Earle, Craig C.
    Tu, Dongsheng
    Jonker, Derek
    Hay, Annette E.
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (09) : 493 - +
  • [6] Incorporating Patient Preferences into Clinical Trial Designs
    Gwinn, Katrina
    ANNALS OF NEUROLOGY, 2018, 84 : S199 - S200
  • [7] Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities
    Wilson, Brooke E.
    Hay, Annette E.
    Chan, Kelvin Kar-Wing
    Cheung, Matthew C.
    Hanna, Timothy P.
    BMJ OPEN, 2023, 13 (08):
  • [8] Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective
    Broes, Stefanie
    Verbaanderd, Ciska
    Casteels, Minne
    Lacombe, Denis
    Huys, Isabelle
    FRONTIERS IN MEDICINE, 2020, 7
  • [9] Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation
    McNiff, Megan M.
    Hawkins, Sheila
    Haase, Bine
    Bullivant, Joanne
    McIver, Tammy
    Mitelman, Olga
    Emery, Nicholas
    Tasca, Giorgio
    Voermans, Nicol
    Diaz-Manera, Jordi
    JOURNAL OF NEUROMUSCULAR DISEASES, 2024, 11 (02) : 459 - 472
  • [10] A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
    Hay, Annette E.
    Mittmann, Nicole
    Crump, Michael
    Cheung, Matthew C.
    Sleeth, Jessica
    Needham, Judy
    Broekhoven, Mike
    Djurfeldt, Marina
    Shepherd, Lois E.
    Meyer, Ralph M.
    Chen, Bingshu E.
    Pater, Joseph L.
    CURRENT ONCOLOGY, 2021, 28 (02) : 1153 - 1160